Steve Auten
Chair of Pharma & Life Sciences Litigation at Taft Stettinius & Hollister Llp
Based in United States
7-day free trial · no credit card
Seniority
C-Team
Department
Legal
Location
United States
Industry
Law Practice
Company size
2.2K
Contact information
Reveal Steve's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
s•••••••@taftlaw.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Steve Auten
STEVE AUTEN is head of Taft's Pharmaceutical & Life Sciences Litigation practice area. He is a widely recognized attorney in Hatch-Waxman and biosimilar matters, including related patent litigation, and is followed by key industry leaders (brand and generic alike), law firms, analysts, educators and others on his LinkedIn blog "Hatch Waxman ANDA Litigation Forum" or HALF, which has nearly members. He currently represents clients primarily in the areas of Paragraph IV design strategies, Hatch-Waxman litigation, and biosimilar market opportunities.He is counsel to many companies, large and small, including those who are first-to-file an ANDA with a P-IV certification, and thus eligible for 180-days of market exclusivity. His prior in-house role gives him unique perspective in communicating to the C-suite, meeting budgets, and managing expectations. He adds value in not only getting results, but also managing case budgets prudently and effectively based on forecasted NPVs. A frequent author, Steve was a co-editor of "Pre-ANDA Litigation: Strategies & Tactics for Developing a Drug Product and Patent Portfolio." He personally inked the chapter on "Citizen Petitions," sharing his knowledge about the intersection of FDA, patent, and Hatch-Waxman laws. He also served as an associate editor and chapter author for "ANDA Litigation: Strategies & Tactics for Pharmaceutical Patent Litigators." Steve served as co-editor yet again on "Evidence in Patent Cases," also co-authoring the chapter on Hatch-Waxman cases.Well-recognized by industry and his peers, Steve was named in 2017 by Corporate INTL as the Life Sciences Attorney of the Year for the State of Illinois. He also was a national finalist in 2018 for Hatch-Waxman Litigator of the Year (generic) by LMG Life Sciences. Clients noted for Chambers USA that Steve "is very strategic,""has a commanding knowledge of the generic pharmaceutical patent litigation space,""gives very practical advice," and "is commercially aware." Steve is also ranked among the Best Lawyers in America, Top 100 High Stakes Litigators, IAM Patent Illinois Super Lawyers, and Illinois Leading Lawyers. In 2019, Crain's Chicago Business named Steve a Generation X Leader in Law.Most recently, in 2023, Patexia’s ANDA litigation report recognized Taft as the #1 Best Performing Law Firm for ANDA Defendants and among the top 10 most active of all ANDA firms (plaintiff or defendant). They also ranked Steve individually at #7 out of 842 defense attorneys.
Decision-makers
Other people at Taft Stettinius & Hollister Llp
Build a list of verified contacts at Taft Stettinius & Hollister Llp
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Steve
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime